EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Non-BRCA germline pathogenic variants and response to neoadjuvant systemic therapy in triple-negative breast cancer patients enrolled in a prospective clinical trial

Kamaria L Lee, Clinton Yam, Li Zhao, Roland L Bassett, Xingzhi Song, Alastair M Thompson, Jason B White, Rachel M Layman, Lei Huo, Angelica M Gutierrez, Vicente Valero, Naoto T Ueno und 10 weitere

Breast Cancer Research and Treatment · 2026-06 · 217 (2)

DOI: 10.1007/s10549-026-07985-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, online erschienen am 01.06.2026. Verfasst von Kamaria L Lee und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Germ-Line Mutation, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, CPRIT, National Cancer Institute, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsGerm-Line MutationAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleNeoadjuvant TherapyMiddle AgedPathologic Complete ResponseAdultProspective StudiesTreatment OutcomeAgedCyclophosphamideGenetic Predisposition to Disease

Stichwörter der Autor:innen

Breast cancerNeoadjuvant therapyPathogenic variantsPathologic complete responseTriple-negative breast cancer

Substanzen

Cyclophosphamide

Autor:innen und Institutionen

  • Department of Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Department of Surgical Oncology, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.

Förderung

  • NCI NIH HHS
  • CPRIT
  • National Cancer Institute, National Institutes of Health
  • The University of Texas MD Anderson Cancer Center Moon Shots Program
  • Conquer Cancer Career Development Award
  • Still Water Foundation
  • 2018 Gianni Bonadonna Breast Cancer Research Fellowship
  • Allison and Brian Grove Endowed Fellowship for Breast Medical Oncology

Zitieren

APA

Lee, K. L., Yam, C., Zhao, L., Bassett, R. L., Song, X., Thompson, A. M., White, J. B., Layman, R. M., Huo, L., Gutierrez, A. M., Valero, V., Ueno, N. T., Litton, J. K., Zhang, J., Ravenberg, E., Korkut, A., Adrada, B. E., Candelaria, R. P., Rauch, G. M., …, & Arun, B. K. (2026). Non-BRCA germline pathogenic variants and response to neoadjuvant systemic therapy in triple-negative breast cancer patients enrolled in a prospective clinical trial. Breast Cancer Research and Treatment, 217(2). https://doi.org/10.1007/s10549-026-07985-7

Vancouver

Lee KL, Yam C, Zhao L, Bassett RL, Song X, Thompson AM, et al. Non-BRCA germline pathogenic variants and response to neoadjuvant systemic therapy in triple-negative breast cancer patients enrolled in a prospective clinical trial. Breast Cancer Research and Treatment. 2026;217(2). doi:10.1007/s10549-026-07985-7

BibTeX
@article{Lee2026,
  author = {Lee, Kamaria L and Yam, Clinton and Zhao, Li and Bassett, Roland L and Song, Xingzhi and Thompson, Alastair M and White, Jason B and Layman, Rachel M and Huo, Lei and Gutierrez, Angelica M and Valero, Vicente and Ueno, Naoto T and Litton, Jennifer K and Zhang, Jianhua and Ravenberg, Elizabeth and Korkut, Anil and Adrada, Beatriz E and Candelaria, Rosalind P and Rauch, Gaiane M and Tripathy, Debu and Shaitelman, Simona F and Arun, Banu K},
  title = {Non-BRCA germline pathogenic variants and response to neoadjuvant systemic therapy in triple-negative breast cancer patients enrolled in a prospective clinical trial},
  journal = {Breast Cancer Research and Treatment},
  year = {2026},
  volume = {217},
  number = {2},
  doi = {10.1007/s10549-026-07985-7}
}
Kostenlos starten →